2009
DOI: 10.3109/14756360903389849
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and biological activity of pyrazolo[3,4-d]thiazolo[3,2-a]pyrimidin-4-one derivatives: in silico approach

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
9
0

Year Published

2010
2010
2019
2019

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 23 publications
(9 citation statements)
references
References 24 publications
0
9
0
Order By: Relevance
“…Development of XO inhibitors with free radical scavengers potential may prove to be promising agents to treat Gout. This encouraged the researchers to develop structurally diverse molecules without purine backbone with promising XO inhibitory activity such as N‐(1,3‐diaryl‐3‐oxopropyl) amides ( 4 ) ,1‐acetyl‐3,5‐diaryl‐4,5‐di‐hydrol(1H) pyrazoles ( 5 ) , Y‐700 ( 6 ) , N‐aryl‐5‐amino‐4‐cyanopyrazole (7) , flavonoids ( 8 ) , anacardic acid ( 9) , thiazolo‐pyrazolyl 5‐phenylisoxazole‐3‐carboxylic acid ( 10 ) , naphthoflavones ( 11 ) , and pyrazolo[3,4‐d] thiazolo[3,2‐a]pyrimidin‐4‐one ( 12 ) , 2‐(3‐cyano‐2‐isopropyl‐1H‐indol‐5‐yl)‐4‐methylthiazole‐5‐carboxylic acid ( 13 ) , derivatives (Figure ). It was assumed worthwhile to rationally design with pharmacophoric approaches to develop structural analogous of febuxostat as non‐purine XO inhibitors with antioxidant activity for diminishing the associated toxicities.…”
mentioning
confidence: 99%
“…Development of XO inhibitors with free radical scavengers potential may prove to be promising agents to treat Gout. This encouraged the researchers to develop structurally diverse molecules without purine backbone with promising XO inhibitory activity such as N‐(1,3‐diaryl‐3‐oxopropyl) amides ( 4 ) ,1‐acetyl‐3,5‐diaryl‐4,5‐di‐hydrol(1H) pyrazoles ( 5 ) , Y‐700 ( 6 ) , N‐aryl‐5‐amino‐4‐cyanopyrazole (7) , flavonoids ( 8 ) , anacardic acid ( 9) , thiazolo‐pyrazolyl 5‐phenylisoxazole‐3‐carboxylic acid ( 10 ) , naphthoflavones ( 11 ) , and pyrazolo[3,4‐d] thiazolo[3,2‐a]pyrimidin‐4‐one ( 12 ) , 2‐(3‐cyano‐2‐isopropyl‐1H‐indol‐5‐yl)‐4‐methylthiazole‐5‐carboxylic acid ( 13 ) , derivatives (Figure ). It was assumed worthwhile to rationally design with pharmacophoric approaches to develop structural analogous of febuxostat as non‐purine XO inhibitors with antioxidant activity for diminishing the associated toxicities.…”
mentioning
confidence: 99%
“…They have also been reported as calcium antagonists [11], group 2 metabotropic glutamate receptor antagonists [12], 5-HT2 receptor antagonists [13,14], and inhibitors of enzymes such as xanthine oxidase [15], acetylcholinesterase [16], and CDC25B phosphatise [17]. Some of the biologically potent thiazolopyrimidine and thiazoloquinazoline derivatives are given in Fig.…”
Section: Introductionmentioning
confidence: 99%
“…Pyrazole derivatives are well known for their applications in fluorescence probes and pharmacological activities such as anti-microbial, antiinflammatory, anti-cancer, and antiviral [20e23]. Recently, pyrazoles were found to possess inhibitory activities against XO, cyclooxygenase, and alkaline phosphatases [24,25]. The modification of pyrazole and oxadiazole such as substituent moiety should provide potential fluorescence properties and biological activities.…”
Section: Introductionmentioning
confidence: 99%